Updated FDA Guidance on Continuous Manufacturing of Drug Substances and Drug Products
Full FDA guidance on Q13 Continuous Manufacturing available for download
Learn more
A Year of Growth and Influence:
Our Biomanufacturing Highlights 2022
Just – Evotec Biologics’ 2022 Highlights
How an Integrated, Continuous, Intensified Approach for Manufacturing Biologics Provides Productivity and Quality Benefits
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Interview CPHI Pharma Awards 2022
Read the interview with Randal Bass, EVP Process Design & Biotherapeutic Operations at Just-Evotec Biologics
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
Read the article describing the latest trends in the biopharmaceutical industry
Intensified continuous bioprocessing supports industry trends
Read the article on our continuous bioprocess platform used at J.POD
Advancing Process Design for Accessible mAb-based Therapeutics
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Why Early mAb Sequence Optimization can Improve Developability and Reduce Costs
Read the article on why early mAb optimization might be right for your project.
Flexible, Continuous Manufacturing Technologies
Read the article on our continuous manufacturing technologies used in our cGMP manufacturing facility J.POD.
Biologics Manufacturing Without the Big Bioreactors
Read the article on our cGMP manufacturing facility J.POD in the June edition of BioProcess Int.
Automated multi-attribute method sample preparation using high-throughput buffer exchange tips
In recent years, the multi-attribute method (MAM) has become an important mass spectrometry-based tool for identifying and quantifying the site-specific product attributes and purity information…
Development of recombinase-based targeted integration systems for production of exogenous proteins using transposon-mediated landing pads
Current methods for stably expressing biotherapeutics in CHO cells often rely on random or semi-random integration events which result in widely heterogeneous cell populations. In…